TABLE 1.
Demographic and clinical characteristics of the recurrent and non-recurrent groups.
| Recurrent group (n = 22) | Non-recurrent group (n = 42) | p-value | |
| Age (years) | 62.2 ± 12.4 | 59.9 ± 10.3 | 0.421 |
| Male n (%) | 11 (50) | 24 (57.1) | 0.586 |
| BMI (kg/m2) | 25.4 ± 2.2 | 26.1 ± 3.0 | 0.36 |
| Persistent AF n (%) | 11 (50) | 10 (23.8) | 0.038 |
| AF history duration (years) | 5.8 ± 4.6 | 6.8 ± 4.4 | 0.386 |
| Time to recurrence (years) | 1.6 ± 0.9 | 2.4 ± 1.9 | 0.073 |
| Co-morbidity | |||
| Hypertension n (%)break | 12 (54.5) | 17 (40.5) | 0.285 |
| Diabetes n (%) | 6 (27.3) | 2 (4.8) | 0.02 |
| CHD n (%) | 4 (18.2) | 2 (4.8) | 0.102 |
| CHA2DS2-VASc | 2.1 ± 1.7 | 1.3 ± 1.1 | 0.051 |
| HASBLED | 1.5 ± 0.9 | 0.9 ± 0.8 | 0.105 |
| Echocardiogram | |||
| LAD (mm) | 40.3 ± 4.8 | 38.7 ± 5.9 | 0.305 |
| LVDd (mm) | 49.0 ± 6.2 | 46.4 ± 3.6 | 0.065 |
| LVEF (%) | 62.1 ± 5.4 | 63.3 ± 3.4 | 0.344 |
AF, atrial fibrillation; BMI, body mass index; CHD, coronary heart disease; LAD, left atrial dimeter; LVDd, left ventricular diastolic dimeter; LVEF, left ventricular ejection fraction; PV, pulmonary vein; SVC, superior vena cava.